BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22179005)

  • 61. New pyrimido-indole compound CD-160130 preferentially inhibits the KV11.1B isoform and produces antileukemic effects without cardiotoxicity.
    Gasparoli L; D'Amico M; Masselli M; Pillozzi S; Caves R; Khuwaileh R; Tiedke W; Mugridge K; Pratesi A; Mitcheson JS; Basso G; Becchetti A; Arcangeli A
    Mol Pharmacol; 2015 Feb; 87(2):183-96. PubMed ID: 25411366
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia.
    Agarwal JR; Griesinger F; Stühmer W; Pardo LA
    Mol Cancer; 2010 Jan; 9():18. PubMed ID: 20105281
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells.
    Guo Y; Shan Q; Gong Y; Lin J; Shi F; Shi R; Yang X
    Pharmazie; 2014 Mar; 69(3):229-33. PubMed ID: 24716415
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.
    Yu J; Peng Y; Wu LC; Xie Z; Deng Y; Hughes T; He S; Mo X; Chiu M; Wang QE; He X; Liu S; Grever MR; Chan KK; Liu Z
    PLoS One; 2013; 8(2):e55934. PubMed ID: 23457487
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Kinetics of drug interaction with the Kv11.1 potassium channel.
    Hill AP; Perrin MJ; Heide J; Campbell TJ; Mann SA; Vandenberg JI
    Mol Pharmacol; 2014 May; 85(5):769-76. PubMed ID: 24586056
    [TBL] [Abstract][Full Text] [Related]  

  • 66. hERG K(+) channels: structure, function, and clinical significance.
    Vandenberg JI; Perry MD; Perrin MJ; Mann SA; Ke Y; Hill AP
    Physiol Rev; 2012 Jul; 92(3):1393-478. PubMed ID: 22988594
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Curcumin and cancer: barriers to obtaining a health claim.
    Devassy JG; Nwachukwu ID; Jones PJ
    Nutr Rev; 2015 Mar; 73(3):155-65. PubMed ID: 26024538
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting ion channels in leukemias: a new challenge for treatment.
    Arcangeli A; Pillozzi S; Becchetti A
    Curr Med Chem; 2012; 19(5):683-96. PubMed ID: 22204341
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Curcumin blocks Kv11.1 (erg) potassium current and slows proliferation in the infant acute monocytic leukemia cell line THP-1.
    Banderali U; Belke D; Singh A; Jayanthan A; Giles WR; Narendran A
    Cell Physiol Biochem; 2011; 28(6):1169-80. PubMed ID: 22179005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of ERG1 isoforms in modulation of ERG1 channel trafficking and function.
    Larsen AP
    Pflugers Arch; 2010 Oct; 460(5):803-12. PubMed ID: 20574821
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Computational Models for Understanding of Structure, Function and Pharmacology of the Cardiac Potassium Channel Kv11.1 (hERG).
    Wacker S; Noskov SY; Perissinotti LL
    Curr Top Med Chem; 2017; 17(23):2681-2702. PubMed ID: 28413954
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.